BioCardia (BCDA) FDA confirms Helix catheter meeting minutes for De Novo
BioCardia (BCDA) says the FDA confirms meeting minutes supporting a follow-on De Novo pre-submission for approval for its Helix transendocardial delivery catheter.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.